Olaf Neumann
Heidelberg University · 96 works · 3,050 citations · h-index 28
Top works
- Accurate and efficient detection of gene fusions from RNA sequencing data
- Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
- Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis
- Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians
- Variant classification in precision oncology
- Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors
- Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma
- Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real‐life analysis of three larger gene panels
- Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts
- Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases
- Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
- EEF1A2 Inactivates p53 by Way of PI3K/AKT/mTOR-Dependent Stabilization of MDM4 in Hepatocellular Carcinoma
- Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)
- Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
- RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples
- Nuclear Pore Component Nup98 Is a Potential Tumor Suppressor and Regulates Posttranscriptional Expression of Select p53 Target Genes
- Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience
- Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival
- RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours
- KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma